RE:RE:RE:Something I just seen !Longholder99 wrote: The positive results have already been demonstrated. It seems like the formalized double blind testing is a formality. Won't be long before it becomes unethical to not allow the placebo group access to the real laser. This is unexpected and another layer to the Theralase story that makes the company a target for buyout.
Longholder99 good point.
Here is an aticle about Light therapy and Parkinson's.
https://apdaparkinson.org/article/light-therapy-for-parkinsons-disease/ Under '' Available light therapy devices''.
It is said'' Because light therapy delivered via the eyes or the skin has minimal side effects,multiple light-emitting devices have already been designed,marketed and are available for purchage
without FDA approval. There are no white-light or red-light therapy device yet on the market that are
designed and marketed specifically for Parkinson's disease''. The above is confirmed by TLT in the press-release /2024/02/12.
TLT said'' Theralase CLT, with its super-pulsed laser technology, is one of the few technology in the world able to non-invasively penetrate the human skull, promoting anti-inflamatory response and stimulating neurons to promote healing from this deadly disease.
'' We are exited to begin the
very first randomized placebo-controled study on laser light therapy in Parkinson's patients''.
In short...
-TLT has over 25 years experience working with Pulsed Laser Technology.
-There is no device on the market specifically designed for Parkinson's patients(TLT will be the first).
-TLT doesn't need FDA approval to market the device.
-TLT is the worldwide largest manufacturer of Super-Pulsed laser technology.
-The market for Parkinson's is huge $$$$$$$$$$$$......
Is just me or TLT could be on to something here.